DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza
Authors:
- J. WillimanJWJ. Williman
- M. BairdMBM. Baird
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007
- The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gunVaccine, 2006
- Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate‐tumour‐associated antigensImmunology, 2006
- Protection against influenza infection by cytokine‐enhanced aerosol genetic immunizationThe Journal of Gene Medicine, 2006
- Understanding the IL-23–IL-17 immune pathwayTrends in Immunology, 2006
- Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivoBlood, 2004
- Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxisJournal of Leukocyte Biology, 2004
- Antibody-mediated delivery of antigen to chemokine receptors on antigen-presenting cells results in enhanced CD4+ T cell responsesEuropean Journal of Immunology, 2003
- Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoterGene Therapy, 2001
- Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNAVaccine, 1995